Description

(S)-2-Methyl-6-Nitro-2-((4-(4-(4-(Trifluoromethoxy)Phenoxy)Piperidin-1-Yl)Phenoxy)Methyl)-2,3-Dihydroimidazo[2,1-B]Oxazole is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure containing a trifluoromethoxy group and a nitroimidazole-oxazole core. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel bioactive molecules. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, especially those targeting central nervous system (CNS) disorders or possessing anti-infective properties.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of potential drug candidates, particularly for CNS-targeted therapies.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to explore and optimize the biological activity of novel chemical entities.
• Active Pharmaceutical Ingredient (API) Development: A key precursor in the development pathway for new APIs, leveraging its unique fused heterocyclic scaffold.
• Biochemical Tool Compound: May be utilized in pharmacological assays to study specific enzyme interactions or receptor binding due to its distinct chemical structure.
• Fine Chemical Synthesis: Employed in custom synthesis and contract manufacturing for producing specialized, high-value compounds for research purposes.

Basic Information

Product Name	(S)-2-Methyl-6-Nitro-2-((4-(4-(4-(Trifluoromethoxy)Phenoxy)Piperidin-1-Yl)Phenoxy)Methyl)-2,3-Dihydroimidazo[2,1-B]Oxazole
CAS No.	681505-01-1
Molecular Formula	C30H27F3N4O6
Molecular Weight	596.56 g/mol
Synonyms	(S)-2-Methyl-6-nitro-2-{[4-(4-{[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b][1,3]oxazole; UNII-8KQ3KQJ0F9; 8KQ3KQJ0F9; CHEMBL3186470; BDBM50157857; AKOS009158974; (S)-2-Methyl-6-nitro-2-((4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)methyl)-2,3-dihydroimidazo[2,1-b]oxazole
EINECS	Contact for details

Quality Control

Our (S)-2-Methyl-6-Nitro-2-((4-(4-(4-(Trifluoromethoxy)Phenoxy)Piperidin-1-Yl)Phenoxy)Methyl)-2,3-Dihydroimidazo[2,1-B]Oxazole is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.